Health Affairs

Health Affairs, 26, no. 2 (2007): 450-457 doi: 10.1377/hlthaff.26.2.450 © 2007 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Figures Only Full Text (HTML) Reprint (PDF) Supplemental Exhibits Submit a response to this article Comments: View responses Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Scheffler, R. M. Articles by Levine, P. Search for Related Content PubMed Articles by Scheffler, R. M. Articles by Levine, P. Related Collections International Issues Maternal And Child Health Business Of Health Mental Health/Substance Abuse Pharmaceuticals Health Spending Consumer Issues

Health Tracking

TRENDS

The Global Market For ADHD Medications

Richard M. Scheffler, Stephen P. Hinshaw, Sepideh Modrek and Peter Levine

Little is known about the global use and cost of medications for attention deficit hyperactivity disorder (ADHD). Global use of ADHD medications rose threefold from 1993 through 2003, whereas global spending (U.S. $2.4 billion in 2003) rose ninefold, adjusting for inflation. Per capita gross domestic product (GDP) robustly predicted use across countries, but the United States, Canada, and Australia showed significantly higher-than-predicted use. Use and spending grew in both developed and developing countries, but spending growth was concentrated in developed countries, which adopted more costly, long-acting formulations. Promoting optimal prescription and monitoring should be a priority.

                      What's this?

This article has been cited by other articles:

				D. H. Howard, L. C. Richardson, and K. E. Thorpe Cancer Screening And Age In The United States And Europe Health Aff., November 1, 2009; 28(6): 1838 - 1847. [Abstract] [Full Text] [PDF]

				B. D. Fulton, R. M. Scheffler, S. P. Hinshaw, P. Levine, S. Stone, T. T. Brown, and S. Modrek National Variation of ADHD Diagnostic Prevalence and Medication Use: Health Care Providers and Education Policies Psychiatr Serv, August 1, 2009; 60(8): 1075 - 1083. [Abstract] [Full Text] [PDF]

				R. M. Scheffler, T. T. Brown, B. D. Fulton, S. P. Hinshaw, P. Levine, and S. Stone Positive Association Between Attention-Deficit/ Hyperactivity Disorder Medication Use and Academic Achievement During Elementary School Pediatrics, May 1, 2009; 123(5): 1273 - 1279. [Abstract] [Full Text] [PDF]

				L. M. Furman Attention-Deficit Hyperactivity Disorder (ADHD): Does New Research Support Old Concepts? J Child Neurol, July 1, 2008; 23(7): 775 - 784. [Abstract] [PDF]

Comments: